Yocca Frank - Insider Non-Derivative Transactions at BioXcel Therapeutics, Inc. (BTAI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 16, 2024, Yocca Frank's relationship to BioXcel Therapeutics, Inc. (BTAI) is Officer (Chief Scientific Officer), and currently has 14,203 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BTAI insiders.
Data Source: SEC.
Yocca Frank - Insider Non-Derivative Transactions of BTAI Common Stock
Yocca Frank - Insider Non-Derivative Transactions at BTAI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 17, 2024 | Sell -- (Common Stock) | 355 | 0.69 | 14203 |
| Sep 16, 2024 | M -- (Common Stock) | 563 | 0 | 14558 |
| Sep 15, 2024 | M -- (Common Stock) | 521 | 0 | 13995 |
| Jun 18, 2024 | Sell -- (Common Stock) | 372 | 1.28 | 13474 |
| Jun 16, 2024 | M -- (Common Stock) | 562 | 0 | 13846 |
| Jun 15, 2024 | M -- (Common Stock) | 521 | 0 | 13284 |
| Apr 5, 2024 | Sell -- (Common Stock) | 1067 | 2.64 | 12763 |
| Mar 16, 2024 | M -- (Common Stock) | 2250 | 0 | 13830 |
| Mar 15, 2024 | M -- (Common Stock) | 521 | 0 | 11580 |
| Dec 15, 2023 | M -- (Common Stock) | 521 | 0 | 11059 |
| Sep 15, 2023 | M -- (Common Stock) | 521 | 0 | 10538 |
| Jun 15, 2023 | M -- (Common Stock) | 521 | 0 | 10017 |
| Mar 16, 2023 | Sell -- (Common Stock) | 985 | 19.69 | 9496 |
| Mar 15, 2023 | M -- (Common Stock) | 2084 | 0 | 10481 |
| Jan 21, 2023 | Sell -- (Common Stock) | 50000 | 30 | 8397 |